Not exact matches
The VC - 01 product candidate is being
developed as a potential long - term diabetes treatment with the goals of no
immune suppression required, and a reduced risk of hypoglycemia and diabetes - related complications.
The VC - 01 product candidate is being
developed as a potential long - term diabetes treatment with the goal of reducing the risk of hypoglycemia and diabetes - related complications without requiring long - term
immune suppression.
VC - 01 is being
developed as a potential long - term diabetes treatment without
immune suppression, and without risk of hypoglycemia or other diabetes - related complications.
With prolonged drug
suppression, stress, or
immune system breakdown, the cancerous cells
develop into a mass that absorbs vital nutrients, presses against surrounding tissues, and may eventually cause death.
Two theories1 exist about why certain dogs
develop demodectic mange, both of which deal with
suppression of the
immune system.